SV2A and chronic myelogenous leukemia, BCR-ABL1 positive: The regulatory landscape of SV2A is intricate, involving the transcription factor CREB1 and the microRNA has-miR-16-5p, suggesting a critical checkpoint in SV2A expression control within CML cells.